Masur H - Search Results

1

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, Metcalf JA, Walker RE, Falloon J, Baseler M, Feuerstein I, Masur H, Lane HC. Connors M, et al. Among authors: masur h. Nat Med. 1997 May;3(5):533-40. doi: 10.1038/nm0597-533. Nat Med. 1997. PMID: 9142122

2

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.

Walker RE, Carter CS, Muul L, Natarajan V, Herpin BR, Leitman SF, Klein HG, Mullen CA, Metcalf JA, Baseler M, Falloon J, Davey RT Jr, Kovacs JA, Polis MA, Masur H, Blaese RM, Lane HC. Walker RE, et al. Among authors: masur h. Nat Med. 1998 Jul;4(7):852-6. doi: 10.1038/nm0798-852. Nat Med. 1998. PMID: 9662381

3

Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion.

Miller KD, Spooner K, Herpin BR, Rock-Kress D, Metcalf JA, Davey RT Jr, Falloon J, Kovacs JA, Polis MA, Walker RE, Masur H, Lane HC. Miller KD, et al. Among authors: masur h. Clin Immunol. 2001 Apr;99(1):30-42. doi: 10.1006/clim.2001.5001. Clin Immunol. 2001. PMID: 11286539 Clinical Trial.

4

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, Metcalf JA, Sereti I, Polis MA, Davey RT, Tavel J, Falloon J, Stevens R, Lambert L, Dewar R, Schwartzentruber DJ, Anver MR, Baseler MW, Masur H, Dimitrov DS, Lane HC. Kovacs JA, et al. Among authors: masur h. J Exp Med. 2001 Dec 17;194(12):1731-41. doi: 10.1084/jem.194.12.1731. J Exp Med. 2001. PMID: 11748275 Free PMC article.

5

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.

Lane HC, Falloon J, Walker RE, Deyton L, Kovacs JA, Masur H, Banks S, Kirk LE, Baseler MW, Salzman NP, et al. Lane HC, et al. Among authors: masur h. Ann Intern Med. 1989 Jul 1;111(1):41-50. doi: 10.7326/0003-4819-111-1-41. Ann Intern Med. 1989. PMID: 2735626 Clinical Trial.

6

Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).

Polis MA, deSmet MD, Baird BF, Mellow S, Falloon J, Davey RT Jr, Kovacs JA, Palestine AG, Nussenblatt RB, Masur H, et al. Polis MA, et al. Among authors: masur h. Am J Med. 1993 Feb;94(2):175-80. doi: 10.1016/0002-9343(93)90180-w. Am J Med. 1993. PMID: 8381583 Review.

7

Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.

Davey RT Jr, Dewar RL, Reed GF, Vasudevachari MB, Polis MA, Kovacs JA, Falloon J, Walker RE, Masur H, Haneiwich SE, et al. Davey RT Jr, et al. Among authors: masur h. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5608-12. doi: 10.1073/pnas.90.12.5608. Proc Natl Acad Sci U S A. 1993. PMID: 8516307 Free PMC article. Clinical Trial.

8

Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial.

Kovacs JA, Bechtel C, Davey RT Jr, Falloon J, Polis MA, Walker RE, Metcalf JA, Davey V, Piscitelli SC, Baseler M, Dewar R, Salzman NP, Masur H, Lane HC. Kovacs JA, et al. Among authors: masur h. J Infect Dis. 1996 Apr;173(4):840-8. doi: 10.1093/infdis/173.4.840. J Infect Dis. 1996. PMID: 8603961 Clinical Trial.

9

Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.

Walker RE, Spooner KM, Kelly G, McCloskey RV, Woody JN, Falloon J, Baseler M, Piscitelli SC, Davey RT Jr, Polis MA, Kovacs JA, Masur H, Lane HC. Walker RE, et al. Among authors: masur h. J Infect Dis. 1996 Jul;174(1):63-8. doi: 10.1093/infdis/174.1.63. J Infect Dis. 1996. PMID: 8656014

10

Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.

Davey RT Jr, Chaitt DG, Reed GF, Freimuth WW, Herpin BR, Metcalf JA, Eastman PS, Falloon J, Kovacs JA, Polis MA, Walker RE, Masur H, Boyle J, Coleman S, Cox SR, Wathen L, Daenzer CL, Lane HC. Davey RT Jr, et al. Among authors: masur h. Antimicrob Agents Chemother. 1996 Jul;40(7):1657-64. doi: 10.1128/AAC.40.7.1657. Antimicrob Agents Chemother. 1996. PMID: 8807058 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

515 results

Search Page